Home / Medicine / Claritine

Medicines with the same recorded active ingredients

These listings match the full ingredient set recorded for Claritine. Strength, dosage form and route may differ or be missing. This does not establish interchangeability; confirm a suitable product with a pharmacist.

Incompatibilities

Not applicable.

Preclinical safety data

Preclinical data reveal no special hazard based on conventional studies of safety, pharmacology, repeated dose toxicity, genotoxicity and carcinogenic potential.

In reproductive toxicity studies, no teratogenic effects were observed. However, prolonged parturition and reduced viability of offspring were observed in rats at plasma levels (AUC) 10 times higher than those achieved with clinical doses.

No evidence of mucous membrane irritation was observed after daily administration of up to 12 tablets (120 mg) of oral lyophilisates into the hamster cheek pouch for five days.

Special precautions for disposal and other handling

No special requirements.